CDC recommends Novavax’s COVID-19 vaccine to be used as primary series option for adolescents

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo that Novavax’s COVID-19 vaccine be used as another primary series option for adolescents ages 12 through 17.